Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Initiation
SVB Leerink bullish on Reneo Pharmaceuticals, initiates with an Outperform » 08:38
05/04/21
05/04
08:38
05/04/21
08:38
RPHM

Reneo Pharmaceuticals

/

+

As previously reported,…

As previously reported, SVB Leerink analyst Joseph Schwartz initiated coverage of Reneo Pharmaceuticals with an Outperform rating and $25 price target. The analyst notes that Reneo is a clinical-stage biopharma company aiming to unlock the potential of peroxisome proliferator-activated receptor delta agonists in rare mitochondrial diseases. While PPARdelta has been controversial in the past due to a history of preclinical safety issues, the seasoned management team is leveraging their scientific and industry knowledge to develop their candidate where the risk/benefit is favorable, Schwartz contends.

ShowHide Related Items >><<
RPHM Reneo Pharmaceuticals
/

+

05/04/21 SVB Leerink
Reneo Pharmaceuticals initiated with an Outperform at SVB Leerink
05/04/21 Jefferies
Reneo Pharmaceuticals initiated with a Buy at Jefferies
05/04/21 Piper Sandler
Reneo Pharmaceuticals initiated with an Overweight at Piper Sandler
  • 09
    Apr
RPHM Reneo Pharmaceuticals
/

+

Initiation
Reneo Pharmaceuticals initiated with an Outperform at SVB Leerink » 07:40
05/04/21
05/04
07:40
05/04/21
07:40
RPHM

Reneo Pharmaceuticals

/

+

SVB Leerink initiated…

SVB Leerink initiated coverage of Reneo Pharmaceuticals with an Outperform rating and $25 price target.

ShowHide Related Items >><<
RPHM Reneo Pharmaceuticals
/

+

05/04/21 Jefferies
Reneo Pharmaceuticals initiated with a Buy at Jefferies
05/04/21 Piper Sandler
Reneo Pharmaceuticals initiated with an Overweight at Piper Sandler
  • 09
    Apr
RPHM Reneo Pharmaceuticals
/

+

Initiation
Reneo Pharmaceuticals initiated with a Buy at Jefferies » 06:31
05/04/21
05/04
06:31
05/04/21
06:31
RPHM

Reneo Pharmaceuticals

/

+

Jefferies analyst Eun…

Jefferies analyst Eun Yang initiated coverage of Reneo Pharmaceuticals with a Buy rating and $24 price target. The company's single asset, REN001, is in Phase 2b testing for primary mitochondrial myopathies with data due in 2023, noted Yang. The late-stage asset is targeting a large unmet needs and its preclinical and clinical data so far point to early efficacy signals and good safety, said Yang.

ShowHide Related Items >><<
RPHM Reneo Pharmaceuticals
/

+

05/04/21 Piper Sandler
Reneo Pharmaceuticals initiated with an Overweight at Piper Sandler
  • 09
    Apr
RPHM Reneo Pharmaceuticals
/

+

Initiation
Reneo Pharmaceuticals initiated with an Overweight at Piper Sandler » 04:48
05/04/21
05/04
04:48
05/04/21
04:48
RPHM

Reneo Pharmaceuticals

/

+

Piper Sandler analyst…

Piper Sandler analyst Yasmeen Rahimi initiated coverage of Reneo Pharmaceuticals with an Overweight rating and $45 price target. The company has a "product-within-a-pipeline" with REN001, which can "jumpstart" mitochondrial biogenesis and increase fatty acid oxidation and has "strong proof-of-concept data de-risking" clinical development in three orphan mitochondrial diseases, Rahimi tells investors in a research note. The analyst believes Reneo is "undervalued and represents a buying opportunity."

ShowHide Related Items >><<
  • 09
    Apr
RPHM Reneo Pharmaceuticals
/

+

Over a month ago
On The Fly
Opening Day: Phone maker UTime soars in public debut » 08:39
04/10/21
04/10
08:39
04/10/21
08:39
SVFD

Save Foods

/

+

, RGCB

Regencell Bioscience

/

+

, RPHM

Reneo Pharmaceuticals

$13.89 /

-1.64 (-10.56%)

, VECT

Vectivbio

$24.01 /

+1.11 (+4.85%)

, UTME

UTime

$48.63 /

+5.53 (+12.83%)

, COIN

Coinbase

/

+

, AGL

Agilon Health

/

+

, SWIM

Latham Group

$10.45 /

+ (+0.00%)

, EDR

Endeavor

$41.49 /

+ (+0.00%)

, UBER

Uber

$57.72 /

-0.11 (-0.19%)

, LYFT

Lyft

$60.96 /

-1.07 (-1.72%)

, PFE

Pfizer

$36.60 /

+0.64 (+1.78%)

, INTM

Intermedia Cloud

/

+

Shares of China-based…

ShowHide Related Items >><<
UTME UTime
$48.63 /

+5.53 (+12.83%)

UBER Uber
$57.72 /

-0.11 (-0.19%)

PFE Pfizer
$36.60 /

+0.64 (+1.78%)

LYFT Lyft
$60.96 /

-1.07 (-1.72%)

COIN Coinbase
/

+

SVFD Save Foods
/

+

RGCB Regencell Bioscience
/

+

RPHM Reneo Pharmaceuticals
$13.89 /

-1.64 (-10.56%)

VECT Vectivbio
$24.01 /

+1.11 (+4.85%)

UTME UTime
$48.63 /

+5.53 (+12.83%)

COIN Coinbase
/

+

04/07/21 JMP Securities
Coinbase report shows 'substantial business momentum,' says JMP Securities
03/03/21
Fly Intel: Top five analyst initiations
03/03/21 DA Davidson
Coinbase initiated with a Buy at DA Davidson
AGL Agilon Health
/

+

SWIM Latham Group
$10.45 /

+ (+0.00%)

EDR Endeavor
$41.49 /

+ (+0.00%)

UBER Uber
$57.72 /

-0.11 (-0.19%)

04/05/21 Evercore ISI
Uber assumed with an Outperform at Evercore ISI
04/01/21
Fly Intel: Top five analyst initiations
04/01/21 Jefferies
Uber initiated with a Buy at Jefferies
03/31/21 Wolfe Research
Uber assumed with an Outperform at Wolfe Research
LYFT Lyft
$60.96 /

-1.07 (-1.72%)

04/05/21 Evercore ISI
Lyft assumed with an Outperform at Evercore ISI
03/31/21 Wolfe Research
Lyft assumed with a Peer Perform at Wolfe Research
03/26/21
Fly Intel: Top five analyst initiations
03/26/21 Vertical Research
Lyft initiated with a Buy at Vertical Research
PFE Pfizer
$36.60 /

+0.64 (+1.78%)

04/09/21
Pfizer to host conference call
04/06/21 RBC Capital
Pfizer transferred with a Sector Perform at RBC Capital
03/17/21 Mizuho
AbbVie's FDA request show Xeljanz concerns may bleed to Rinvoq, says Mizuho
02/23/21 B. Riley
B. Riley remains 'aggressive' buyer of Novavax after updated FDA guidance
INTM Intermedia Cloud
/

+

UBER Uber
$57.72 /

-0.11 (-0.19%)

PFE Pfizer
$36.60 /

+0.64 (+1.78%)

LYFT Lyft
$60.96 /

-1.07 (-1.72%)

COIN Coinbase
/

+

  • 15
    Apr
  • 09
    Apr
  • 09
    Apr
  • 07
    Apr
  • 01
    Apr
  • 08
    Jan
UBER Uber
$57.72 /

-0.11 (-0.19%)

PFE Pfizer
$36.60 /

+0.64 (+1.78%)

LYFT Lyft
$60.96 /

-1.07 (-1.72%)

COIN Coinbase
/

+

UBER Uber
$57.72 /

-0.11 (-0.19%)

SVFD Save Foods
/

+

PFE Pfizer
$36.60 /

+0.64 (+1.78%)

LYFT Lyft
$60.96 /

-1.07 (-1.72%)

COIN Coinbase
/

+

UBER Uber
$57.72 /

-0.11 (-0.19%)

PFE Pfizer
$36.60 /

+0.64 (+1.78%)

LYFT Lyft
$60.96 /

-1.07 (-1.72%)

Syndicate
Reneo Pharmaceuticals opens at $15, IPO priced at $15 » 11:19
04/09/21
04/09
11:19
04/09/21
11:19
RPHM

Reneo Pharmaceuticals

/

+

Reneo Pharmaceuticals…

Reneo Pharmaceuticals (RPHM) priced 6.25M shares at $15.00, at the low end of the $15.00-$17.00 target range. Reneo is a clinical stage pharmaceutical company focused on the development and commercialization of therapies for patients with rare genetic mitochondrial diseases. Jefferies, SVB Leerink and Piper Sandler are acting as joint book running managers for the offering.

ShowHide Related Items >><<
  • 09
    Apr
Syndicate
Reneo Pharmaceuticals 6.25M share IPO priced at $15.00 » 06:22
04/09/21
04/09
06:22
04/09/21
06:22
RPHM

Reneo Pharmaceuticals

/

+

The deal priced at low…

The deal priced at low end of $15.00-$17.00 target range. Jefferies, SVB Leerink and Piper Sandler are acting as joint book running managers for the offering.

ShowHide Related Items >><<
  • 09
    Apr

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.